Anti-Human EGFR Recombinant Antibody (Cetuximab)

Recombinant monoclonal antibody to Human EGFR. Cetuximab (Erbitux) is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion.
Supplier Creative Biolabs
Product # TAB-003
Pricing Inquiry
Host Human
Target EGFR
Species Reactivity Human
Type IgG1 - kappa
Applications IF, IP, Neut, FuncS, ELISA, FC, ICC, WB, Block, Activ, Inhib
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback